EP1948180
Samsett meðferð við krabbameini sem felur í sér EGFR/HER2 hemla
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
9.11.2006EP published:
13.3.2013EP application number:
06819380.4
EP translation filed:
7.5.2013Grant published:
15.6.2013EPO information:
European Patent Register
Max expiry date:
8.11.2026Expiry date:
8.11.2026
Title:
COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS
Timeline
Owner
Name:
Boehringer Ingelheim International GmbHAddress:
Binger Strasse 173, 55216, Ingelheim am Rhein, DE
Inventor
Name:
SOLCA, FlavioAddress:
Wien, AT
Name:
AMELSBERG, AndreeAddress:
Southbury, CT, US
Name:
STEHLE, GerdAddress:
Ehingen, DE
Name:
VAN MEEL, Jacobus C., A.Address:
Moedling, AT
Name:
BAUM, AnkeAddress:
Wien, AT
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
05110669Date:
11.11.2005Country:
EP
Classification
Categories:
A61K 31/517, A61K 31/00, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 21.10.2013
Expires: 8.11.2014
Payer: G. H. Sigurgeirsson
Number: 9
Paid: 21.10.2014
Expires: 8.11.2015
Payer: G. H. Sigurgeirsson
Number: 10
Paid: 21.10.2015
Expires: 8.11.2016
Payer: G. H. Sigurgeirsson
Number: 11
Paid: 19.10.2016
Expires: 8.11.2017
Payer: G. H. Sigurgeirsson
Number: 12
Paid: 19.10.2017
Expires: 8.11.2018
Payer: G. H. Sigurgeirsson
Number: 13
Paid: 19.10.2018
Expires: 8.11.2019
Payer: G. H. Sigurgeirsson
Number: 14
Paid: 21.10.2019
Expires: 8.11.2020
Payer: G. H. Sigurgeirsson
Number: 15
Paid: 10.11.2020
Expires: 8.11.2021
Payer: G.H. Sigurgeirsson ehf.
Number: 16
Paid: 11.11.2021
Expires: 8.11.2022
Payer: G.H. Sigurgeirsson ehf.
Number: 17
Paid: 11.11.2022
Expires: 8.11.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 18
Paid: 10.11.2023
Expires: 8.11.2024
Payer: G.H. Sigurgeirsson ehf.
Number: 19
Paid: 12.11.2024
Expires: 8.11.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 20
Paid: 11.11.2025
Expires: 8.11.2026
Payer: G.H. Sigurgeirsson ehf.